125. Addictive Psych Meds | Beverley Thomson

125. Addictive Psych Meds | Beverley Thomson

Up next

She Was on 5 Psychiatric Drugs at 27. The Pills Were the Problem All Along | Laura Delano

Laura Delano was diagnosed with bipolar disorder at 14 and spent the next 13 years on psychiatric medications including lithium, Lamictal, Abilify, Effexor, and Ativan.After being labeled “treatment resistant” and nearly ending her life, she started questioning whether the medica ...  Show more

Mitochondrial Transplants Heal Cells | Tom Benson Ep 234

I had Tom Benson, CEO of Mitrix on to discuss mitochondrial transplantation. We covered what mitochondria are, the discovery that your body is constantly delivering fresh mitochondria through your bloodstream (people didn’t know that mitochondria were transferred outside the cell ...  Show more

Recommended Episodes

Ketamine Therapy for Treatment-Resistant Depression
Therapy in a Nutshell

If you have severe depression, PTSD, or anxiety that just won’t go away despite therapy and medication you should know about Ketamine. 30-40% of people with depression have treatment-resistant depression (that means that you’ve tried at least 2 types of medication and it isn't ...

  Show more

On Drugs: Antidepressants
Jacob Hawley: On Love

Comedian Jacob Hawley explores the UK drugs scene. This week he hears about the world of antidepressants: Are they overprescribed? How do they work? Who do they work for? He talks to his best mate Rebecca, and comedians Ahir Shah and Angela Barnes about their relationship to medi ...  Show more

Psychiatric Drugs
Betwixt The Sheets: The History of Sex, Scandal & Society

*WARNING this episode includes adult themes and conversations about mental health and drug use.*


In 2020, the UK government revealed that 17% of the adult population of Britain were prescribed medication for their mental health. But when were these drugs invented? Ho ...

  Show more

Depression und Antidepressiva: Fragliche Ursache, fragliche Wirkung
AMBOSS Podcast – Ärztliches Wissen für Klinik und Praxis

Monoaminmangelhypothese: Studienlage und alternative Erklärungsmodelle